765 filings
Page 23 of 39
4
dy06s 198vtiq
17 Mar 16
THRESHOLD PHARMACEUTICALS / GEORGE GC PARKER ownership change
12:00am
4
0qx8q5u1s796mx9lqhj8
15 Mar 16
THRESHOLD PHARMACEUTICALS / Tillman Pearce ownership change
12:00am
4
fhi4s1dfidrlxr8
15 Mar 16
THRESHOLD PHARMACEUTICALS / Stewart M. Kroll ownership change
12:00am
4
gr38081 mrc
15 Mar 16
THRESHOLD PHARMACEUTICALS / Joel A Fernandes ownership change
12:00am
4
s1lf5sg7 tow
15 Mar 16
THRESHOLD PHARMACEUTICALS / HAROLD E SELICK ownership change
12:00am
S-8
f99oixr
10 Mar 16
Registration of securities for employees
12:00am
8-K
77uc5 19vxthprsfdy
10 Mar 16
Threshold Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Year-End 2015 Financial Results
12:00am
4
69vbn3
1 Mar 16
THRESHOLD PHARMACEUTICALS / WILFRED E JAEGER ownership change
12:00am
4
b35dxxt l3sg78
1 Mar 16
THRESHOLD PHARMACEUTICALS / JEFFREY W BIRD ownership change
12:00am
SC 13G
qinbdltn
16 Feb 16
Threshold Pharmaceuticals Inc
12:00am
SC 13G/A
atslt2q prey8
16 Feb 16
Threshold Pharmaceuticals Inc
12:00am
8-K
7yjs7o
12 Feb 16
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
SC 13G/A
yyn3d5 5ko7mxwpxo
12 Feb 16
Threshold Pharmaceuticals Inc
12:00am
SC 13G/A
opaqh e8033
27 Jan 16
Threshold Pharmaceuticals Inc
12:00am
8-K
s53sjft9m lkce1ff0g
22 Jan 16
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
8-K
rurhz 3wfw
11 Jan 16
Threshold Pharmaceuticals and Merck KGaA, Darmstadt, Germany Agree to Key Terms for the Licensing Back of All Rights to Evofosfamide to Threshold
12:00am
SC 13G/A
yg3xg6aejykha8a
8 Jan 16
Threshold Pharmaceuticals Inc
12:00am
8-K
tjn 2lvge
18 Dec 15
Cost Associated with Exit or Disposal Activities
12:00am
8-K
wpn5jlor3pvgayig
7 Dec 15
Threshold Pharmaceuticals Announces Its Two Phase 3 Studies Evaluating Evofosfamide Did Not Meet Primary Endpoints
12:00am